Latest Breaking News On - Aaron lisberg - Page 1 : comparemela.com

FDA Accepts BLA for Datopotamab Deruxtecan for Nonsquamous NSCLC

The application is based on results of the phase 3 TROPION-Lung01 trial of datopotamab deruxtecan in nonsquamous non–small cell lung cancer (NSCLC), first presented at the 2023 European Society for Medical Oncology Congress.

United statesCaffreym trastuzumabDaiichi sankyoLos angelesSusan galbraithAaron lisbergUniversity of californiaEuropean society for medical oncologyMedical oncologyBiologics license applicationAmerican journalNon small cell lung cancerDatopotamab deruxtecanAntibody drug conjugates

COMING SOON: Dato-DXd vs Docetaxel in Previously Treated Advanced/Metastatic Non–Small Cell Lung Cancer: Results of the Randomized Phase III Study TROPION-Lung01

Aaron Lisberg, MD, provides a look at an upcoming Rapid Readout program looking at the results of the TROPION-Lung01 study investigating Dato-DXd in previously treated patients with advanced/metastatic NSCLC.

Aaron lisbergPreviously treatedMetastatic nonSmall cell lung cancerRandomized phasePartnership withRapid readoutNon small cell lung cancerDatopotamab deruxtecanDato dxdAdvanced non small cell lung cancerMetastatic non small cell lung cancerClinical trial dataNsclc treatment

Dato-DXd Outperforms Docetaxel in Previously Treated, Advanced NSCLC

Patients with previously treated, advanced NSCLC had longer progression-free survival with Dato-DXd than with docetaxel in a phase 3 study.

United statesLos angelesDaiichi sankyoAaron lisbergUniversity of california

Clinical trial finds antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer

Clinical trial finds antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesDaiichi sankyoAaron lisbergHealth jonsson comprehensive cancer centerEuropean society for medical oncologyDavid geffen school of medicineEuropean societyMedical oncologyJonsson comprehensive cancer centerDavid geffen school

Antibody-Drug Conjugate Extends Lives in Lung Cancer Fight

Antibody-Drug Conjugate Extends Lives in Lung Cancer Fight
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan goldmanAaron lisbergEdward garonAmy cummingsDaiichi sankyoDavid geffen school of medicineEuropean society for medical oncologyHealth jonsson comprehensive cancer centerLeadership in developmentHematology oncology clinical research unitEuropean societyMedical oncologyJonsson comprehensive cancer centerDavid geffen schoolOncology clinical research unit